UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enantioselective Synthesis of Fluoro–Dihydroquinazolones and −Benzooxazinones by Fluorination-Initiated Asymmetric Cyclization Reactions

ACS catalysis, 2016-01, Vol.6 (1), p.151-154

2016

Volltextzugriff (PDF)

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

FEBS letters, 2003-08, Vol.550 (1), p.79-83

2003

Volltextzugriff (PDF)

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer

Molecular cancer therapeutics, 2004-01, Vol.3 (1), p.29-37

2004

Volltextzugriff (PDF)

Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent

FEBS letters, 2004-07, Vol.569 (1-3), p.99-104

2004

Volltextzugriff (PDF)

Molecular-Size Reduction of a Potent CXCR4-Chemokine Antagonist Using Orthogonal Combination of Conformation- and Sequence-Based Libraries

Angewandte Chemie (International ed.), 2003-07, Vol.42 (28), p.3251-3253

2003

Volltextzugriff (PDF)

A Mild Method for the Direct Fluorination of Pyrroles by Using a Lipophilic Anionic Phase-Transfer Catalyst

European journal of organic chemistry, 2016-07, Vol.2016 (21), p.3491-3494

2016

Volltextzugriff (PDF)

Asymmetric Fluorination of Enamides: Access to α-Fluoroimines Using an Anionic Chiral Phase-Transfer Catalyst

Journal of the American Chemical Society, 2012-05, Vol.134 (20), p.8376-8379

2012

Volltextzugriff (PDF)

Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event‐related potentials

Psychiatry and clinical neurosciences, 2004-02, Vol.58 (1), p.68-75

2004

Volltextzugriff (PDF)

Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents

Biopolymers, 2007, Vol.88 (2), p.279-289

2007

Volltextzugriff (PDF)

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140

Bioorganic & medicinal chemistry letters, 2001-07, Vol.11 (14), p.1897-1902

2001

Volltextzugriff (PDF)

Benzothiophene derivatives as phosphodiesterase 10A (PDE10A) inhibitors: Hit-to-lead studies

Bioorganic & medicinal chemistry letters, 2019-06, Vol.29 (11), p.1419-1422

2019

Volltextzugriff (PDF)

Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs

Organic & biomolecular chemistry, 2006-01, Vol.4 (12), p.2354-2357

2006

Volltextzugriff (PDF)

Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation

Bioorganic & medicinal chemistry, 2001-08, Vol.9 (8), p.2179-2187

2001

Volltextzugriff (PDF)

Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study

Bioorganic & medicinal chemistry, 2002-05, Vol.10 (5), p.1417-1426

2002

Volltextzugriff (PDF)

Stereoselective Synthesis of [l-Arg-l/d-3-(2-naphthyl)alanine]-Type (E)-Alkene Dipeptide Isosteres and Its Application to the Synthesis and Biological Evaluation of Pseudopeptide Analogues of the CXCR4 Antagonist FC131

Journal of medicinal chemistry, 2005-01, Vol.48 (2), p.380-391

2005

Volltextzugriff (PDF)

Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptidesElectronic supplementary information (ESI) available: experimental procedures, procedures of biological assays, Table S1: characterization data of novel synthetic compounds and HPLC chromatograms for 10E,10K and 10L. See http://www.rsc.org/suppdata/ob/b4/b401485p

Organic & biomolecular chemistry, 2004, Vol.2 (8), p.1255

2004

Volltextzugriff (PDF)

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists

Organic & biomolecular chemistry, 2003-11, Vol.1 (21), p.3663-3669

2003

Volltextzugriff (PDF)

Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives

Organic & biomolecular chemistry, 2003-11, Vol.1 (21), p.3656-3662

2003

Volltextzugriff (PDF)

ChemInform Abstract: A Mild Method for the Direct Fluorination of Pyrroles by Using a Lipophilic Anionic Phase‐Transfer Catalyst

ChemInform, 2016-11, Vol.47 (48), p.no-no

2016

Volltextzugriff (PDF)

Molecular-Size Reduction of a Potent CXCR4-Chemokine Antagonist Using Orthogonal Combination of Conformation- and Sequence-Based Libraries

Angewandte Chemie, 2003-07, Vol.115 (28), p.3373-3375

2003

Volltextzugriff (PDF)

Development of Chemokine Receptor CXCR4 Antagonists Using Bio-mimetic Strategy

Advances in experimental medicine and biology, 2009, Vol.611, p.145-146

2009

Volltextzugriff (PDF)

Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: The insertion of an (E)-alkene dipeptide isostere into the βII'-turn moiety

Bioorganic & medicinal chemistry letters, 2002-03, Vol.12 (6), p.923-928

2002

Volltextzugriff (PDF)

Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides

Organic & biomolecular chemistry, 2004-04, Vol.2 (8), p.1255-1257

2004

Volltextzugriff (PDF)

Regular Article: Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials

Psychiatry and clinical neurosciences, 2004-02, Vol.58 (1), p.68-75

2004

Volltextzugriff (PDF)

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonistsElectronic supplementary information (ESI) available: Fig. S1: behaviors of TF14013, TF14016 and TF14013-Me in mouse serum; Fig. S2: behaviors of TF14002 (a), TF14005 (b), TF14006 (c), TF14013 (d), TF14016 (e) and TF14013 analogs (f) in rat liver homogenate; Table S1: characterization data of novel synthetic peptides; and HPLC charts for synthetic compounds of 4F-benzoyl-TE14011 (

Organic & biomolecular chemistry, 2003-10, Vol.1 (21), p.3663

2003

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(203)

Publikationsform

Sprache

Englisch
(221)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Enantioselective Synthesis of Fluoro–Dihydroquinazolones and −Benzooxazinones by Fluorination-Initiated Asymmetric Cyclization Reactions

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer

Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent

Molecular-Size Reduction of a Potent CXCR4-Chemokine Antagonist Using Orthogonal Combination of Conformation- and Sequence-Based Libraries

A Mild Method for the Direct Fluorination of Pyrroles by Using a Lipophilic Anionic Phase-Transfer Catalyst

Asymmetric Fluorination of Enamides: Access to α-Fluoroimines Using an Anionic Chiral Phase-Transfer Catalyst

Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event‐related potentials

Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140

Benzothiophene derivatives as phosphodiesterase 10A (PDE10A) inhibitors: Hit-to-lead studies

Development of a linear type of low molecular weight CXCR4 antagonists based on T140 analogs

Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation

Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study

Stereoselective Synthesis of [l-Arg-l/d-3-(2-naphthyl)alanine]-Type (E)-Alkene Dipeptide Isosteres and Its Application to the Synthesis and Biological Evaluation of Pseudopeptide Analogues of the CXCR4 Antagonist FC131

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists

Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives

ChemInform Abstract: A Mild Method for the Direct Fluorination of Pyrroles by Using a Lipophilic Anionic Phase‐Transfer Catalyst

Molecular-Size Reduction of a Potent CXCR4-Chemokine Antagonist Using Orthogonal Combination of Conformation- and Sequence-Based Libraries

Development of Chemokine Receptor CXCR4 Antagonists Using Bio-mimetic Strategy

Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: The insertion of an (E)-alkene dipeptide isostere into the βII'-turn moiety

Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides

Regular Article: Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials

Suchergebnisse filtern